Price
No data yet.
Social Signal Score
Analyst Ratings
26 analystsRevenue
$1.69B+131.92%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Emmanuel Ligner
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 13,500
- Beta
- 0.90
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 1.83
Financials
Revenue
$1.69B+131.9%Net Income
$38.10MEBITDA
$226.20MFree Cash Flow
$140.60MEPS (diluted)
$0.06Shares Outstanding (diluted)
677.20M+37.1%Operating Expenses
$415.20MCash & Debt
$306.80MReturn of Capital
$300.0KRevenue by Segment (annual)
$6.55BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $6.55B | $-530.20M | $-0.78 |
| 2024 | $6.78B | $711.50M | $1.05 |
| 2023 | $6.97B | $321.10M | $0.48 |
| 2022 | $7.51B | $686.50M | $1.02 |
| 2021 | $7.39B | $572.60M | $0.86 |
| 2020 | $6.39B | $116.60M | $0.09 |
| 2019 | $6.04B | $37.80M | $-0.84 |
| 2018 | $5.86B | $-86.90M | $-0.72 |
| 2017 | $1.25B | $-112.70M | $-0.84 |
| 2016 | $691.30M | $-42.40M | $-0.09 |
| 2015 | $636.90M | $21.60M | $0.04 |
Valuation
AVTRhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80+0.00%Social Signal Score
Mentions (8)
- Newsprnewswire.com·5d ago·Negative
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026 RADNOR, Pa., Oct. 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, will release its third quarter 2026 financial results before the market opens on Wednesday, October 28, and will hold a related conference call on the same day at 8:00 a.m.
View source ↗ - Newsprnewswire.com·15d ago·Negative
Avantor appoints new Chief Financial Officer RADNOR, Pa., Sept. 21, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, appoints Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026.
View source ↗ - Newszacks.com·18d ago·Neutral
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC AVTR expands its RIM single-use bioprocessing portfolio across APAC, boosting access to locally made solutions and supporting its bioprocessing growth push.
View source ↗ - Newszacks.com·20d ago·Neutral
Here's Why You Should Add Avantor Stock to Your Portfolio for Now AVTR's strong Q2 results, improving orders and raised 2026 outlook support growth prospects, though BMP weakness and uneven demand remain concerns.
View source ↗ - Newszacks.com·32d ago·Negative
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year? Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
View source ↗ - News (RSS)seekingalpha·39d ago·Positive
Avantor: Smaller Green Shoots Of Organic Growth Returning Are Well Priced In
View source ↗ - Newszacks.com·42d ago·Positive
Is Avantor a Buy as Revival Progress Faces Persistent Margin Pressure? AVTR's Revival Program is lifting VWR growth and BMP orders, but margin pressure and soft earnings keep the recovery selective despite a higher 2026 outlook.
View source ↗ - Newsdefenseworld.net·45d ago·Negative
Advisors Capital Management LLC Invests $4.37 Million in Avantor, Inc. $AVTR Advisors Capital Management LLC purchased a new position in shares of Avantor, Inc. (NYSE: AVTR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 441,317 shares of the company's stock, valued at approximately $4,369,000. Advisors Capital Management LLC owned about 0.07% of
View source ↗
Earnings
Wed, Nov 4(in 4 weeks)
Consensus estimate $0.21 per share
Typical surprise +4.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 29$0.21 vs $0.19beat
- Wed, Apr 29$0.17 vs $0.16beat
- Wed, Feb 11$0.22 vs $0.21beat
- Wed, Oct 29$0.22 vs $0.22miss
- Fri, Aug 1$0.24 vs $0.25miss
- Fri, Apr 25$0.23 vs $0.23miss
Estimates and results for AVTR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by AVTR officers and directors.
- Bought
- $11.3m
- Sold
- $40k
14 trades
1 trade
- Lucier Gregory Tbought
- Dingemans Simonbought
- Mehra Sanjeev Kbought
- Lucier Gregory Tbought
- Summe Gregory Lbought
- Mehra Sanjeev Kbought
- Ligner Emmanuelbought
- Summe Gregory Lbought
85 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Gilbert Ray Cisneroshouse · CA31 · disclosed Sep 12, 2025 (30d later)Sell$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA31 · disclosed Sep 12, 2025 (31d later)Sell$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA31 · disclosed Aug 15, 2025 (23d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (57d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (63d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 8, 2024 (28d later)Sell$1,001 - $15,000
- John Jameshouse · MI10 · disclosed Sep 6, 2024 (2d later)Sell$1,001 - $15,000
- John Jameshouse · MI10 · disclosed Sep 2, 2024 (297d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (14d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (13d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (26d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (14d later)Sell$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (27d later)Sell$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (22d later)Sell$1,001 - $15,000
- Daniel Goldmanhouse · NY10 · disclosed Aug 13, 2023 (32d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 11, 2023 (13d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 11, 2023 (18d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 11, 2023 (26d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 11, 2023 (28d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 12, 2023 (42d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.